This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Molina (MOH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $115.25, marking a -0.59% move from the previous day.
Strategic Acquisitions Aid Revenue Growth at Ensign Group
by Zacks Equity Research
Ensign Group's (ENSG) series of strategic buyouts aids its top line and the trend is expected to continue.
Why Should You Retain Centene (CNC) Stock in Your Portfolio?
by Zacks Equity Research
Banking on a rising revenue base and an inorganic growth strategy, Centene (CNC) holds enough potential to reap benefits for investors.
MEDNAX Teams Up With CENTA to Expand Services in Florida
by Zacks Equity Research
MEDNAX (MD) inks a partnership deal with CENTA to strengthen its profile of varied healthcare solutions in Florida.
Why Anthem (ANTM) is an Attractive Pick for Your Portfolio
by Zacks Equity Research
Riding high on strategic buyouts, partnerships and a strong revenue flow, Anthem (ANTM) holds potential to reap benefits for investors.
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Is Molina (MOH) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Should You Retain WellCare Health in Your Portfolio?
by Zacks Equity Research
Riding on increasing membership and inorganic growth strategies, WellCare Health (WCG) holds potential to reap benefits for investors. Besides, the company inks a merger deal with Centene in 2020.
Why Should You Hold Community Health in Your Portfolio?
by Zacks Equity Research
Banking on divestitures and buyouts along with restructuring plans, Community Health (CYH) holds potential to reap benefits for investors.
The Zacks Analyst Blog Highlights: Molina, NRG, Kinross Gold, Apple and Home Depot
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Molina, NRG, Kinross Gold, Apple and Home Depot
Chances of Rate Cut Rise on Jobs Slowdown: Winners & Losers
by Tirthankar Chakraborty
With an overwhelming majority of observers seeing an imminent rate cut on August's soft employment report, certain sectors stand to gain, while some will suffer. Take a look -
Centene's Unit, Canopy Health Extend Ties to Improve Care
by Zacks Equity Research
Centene's (CNC) subsidiary Health Net extends collaboration with Canopy Health to cater wider reach to its CaIPERS members.
Molina Healthcare Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Molina Healthcare has been struggling lately, but the selling pressure may be coming to an end soon.
Ensign Group Acquires Nursing Facility to Expand in Idaho
by Zacks Equity Research
Ensign Group (ENSG) purchases the real estate and the operations of Temple View Transitional Care Center in Idaho to boost its presence in the state.
Humana (HUM) Ties Up to Boost Medicare Advantage Network
by Zacks Equity Research
Humana (HUM) collaborates with Iora Health to strengthen its Medicare Advantage network across Texas, Georgia and Arizona.
Mednax Collaborates With Northern Indiana Neonatal Associates
by Zacks Equity Research
Mednax (MD) joins forces with Northern Indiana Neonatal Associates in Fort Wayne to enhance its neonatal services.
Here's Why Cigna (CI) is an Attractive Investment Option Now
by Zacks Equity Research
Cigna (CI) remains well poised for growth on the back of Express Scripts acquisition.
Ensign Group to Spin Off Home Health & Hospice Business
by Zacks Equity Research
Ensign Group (ENSG) to separate its home health and hospice business from the parent company.
Why Is Molina (MOH) Down 4.4% Since Last Earnings Report?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Buy Stocks for August 29th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
Magellan Healths Growth Measures Aid Investors' Confidence
by Zacks Equity Research
Magellan Health's (MGLN) initiatives to add new business and reduce cost of goods sold aid growth.
Humana Ties Up to Enhance Facilities for Members in Michigan
by Zacks Equity Research
Humana (HUM) teams up with McLaren Physician Partners to provide in-network access to its members in Michigan.
Is Molina Healthcare (MOH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Is Molina (MOH) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Ensign Group (ENSG) Up 33.2% in a Year: More Room for Rally?
by Zacks Equity Research
Ensign Group's (ENSG) revenue stream and strategic initiatives should bolster revenue growth. This will likely support its share price going forward.